What MOMENTA PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Wheeler Craig A | President & CEO | Oct 01 | Disposition to Issuer · D | −389,120 | — | — | 0 |
| Wheeler Craig A | President & CEO | Oct 01 | Disposition to Issuer · D | −48,263 | — | — | 0 |
| Wheeler Craig A | President & CEO | Oct 01 | Disposition to Issuer · D | −36,725 | — | — | 0 |
| Wheeler Craig A | President & CEO | Oct 01 | Disposition to Issuer · D | −8,739 | — | — | 0 |
| Carvajal Alejandra | Chief Legal Officer | Oct 01 | Disposition to Issuer · D | −28,795 | — | — | 0 |
| Manning Anthony M. | Chief Scientific Officer | Oct 01 | Disposition to Issuer · D | −12,778 | — | — | 0 |
| Gemayel Georges | Director | Oct 01 | Disposition to Issuer · D | −14,090 | — | — | 0 |
| Stoner Elizabeth | Director | Oct 01 | Disposition to Issuer · D | −35,509 | — | — | 0 |
| Cieplinska Agnieszka | Chief Accounting Officer (PAO) | Oct 01 | Disposition to Issuer · D | −8,136 | — | — | 0 |
| Arroyo Santiago | SVP, Chief Medical Officer | Oct 01 | Disposition to Issuer · D | −26 | — | — | 0 |
| Beltramello Jo Ann | Chief HR and Inf. Officer | Oct 01 | Disposition to Issuer · D | −57,157 | — | — | 0 |
| Kwon Young | Chief Financial & Bus. Officer | Oct 01 | Disposition to Issuer · D | −160,633 | — | — | 0 |
| Downey Bruce | Director | Oct 01 | Disposition to Issuer · D | −41,844 | — | — | 0 |
| Gilman Steven C | Director | Oct 01 | Disposition to Issuer · D | −7,796 | — | — | 0 |
| Wheeler Craig A | President & CEO | Sep 10 | Gift · G | −190,476 | — | — | 389,120 |
| Fier Ian | Chief Mfg and Program Officer | Aug 20 | Open-market sale · S | −383 | $52.17 | −$20K | 0 |
| Fier Ian | Chief Mfg and Program Officer | Aug 20 | Open-market sale · S | −1,425 | $52.17 | −$74.3K | 383 |
| Fier Ian | Chief Mfg and Program Officer | Aug 20 | Exercise / conversion · M | +1,425 | $18.85 | +$26.9K | 1,808 |
| Guiterrez-Ramos Jose Carlos | Director | Aug 19 | Open-market sale · S | −10,000 | $52.09 | −$521K | 0 |
| Guiterrez-Ramos Jose Carlos | Director | Aug 19 | Exercise / conversion · M | +10,000 | $8.59 | +$85.9K | 10,000 |
Loading...
